None listed
Conditions
Interventions
Intervention1: Awareness campaigns
HPV Self swab screening
Visual inspection after acetic acid (manual and artificial intelligence): Implementation research using a variety of quantitative and
qualit
HRHPV positive women will undergoo VIA AND VIA-AI. the eligible positive lesions will be treated with thermocoagulation. Those with noneligible VIA lesions/ obvious cancer will be referred to the hig
Sponsors
Manipal Academy of Higher Education Manipal
Chittaranjan National Cancer Institute Kolkotta
Sikkim Manipal University Sikkim
Sri Dharmasthala Manjunatheshwara College and Hospital of Ayurveda Udupi
St Johns National Academy of Health Sciences SJNAHS Bengaluru
Tata Medical Center Kolkota
Tata Memorial Hospital TMH Mumbai
Eligibility
Inclusion criteria
Inclusion criteria: Screening: Women who are eligible for cervical cancer screening between the age 30-55 years Interviews and Surveys: Both men and women 30-63 years; community leaders and opinion leaders and religious leaders are invited Health workers and managers of healthcare facilities or institutions
Exclusion criteria
Exclusion criteria: Women who are symptomatic with intermenstrual/ postcoital bleed. Virgin, pregnant women and women who have had a hysterectomy done will be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Uptake of screening Timepoint: 22 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Reach: uptake and coverage and contributing factors 1. % of eligible women aware of cervical cancer and screening 2. % of eligible women screened 3. Scores on trust and cancer awareness 4. Effectiveness: adherence to follow-up and referrals 5. % of hrHPV women coming for VIA or Pap smear 6. % of women receiving early treatment 7. % of women referred for advanced care 8. Adoption: implementation fidelity and stakeholders involvement 9. % of health professionals implementing standard procedures including AI-DSS 10. Involvement of authorities in implementation of screening programme 11. Implementation: implementation fidelity 12. Scores in the SARA-cervical cancer surveys 13. Maintenance: commitment of governments, NGOs and funding agencies to continue the improved protocol. 14. Adoption of improved national screening guidelines 15. Adoption of AI-DSSTimepoint: 22 months | — |
Countries
India
Contacts
Public ContactArathi P Rao
Kasturba Medical College, Manipal, Manipal Academy of Higher Education,Manipal
Outcome results
None listed